TABLE 2.
Concentrations of positive Abs measured in the biopsy- negative group
| Patient | Result for indicated assaya |
|||||
|---|---|---|---|---|---|---|
| tTG-IgA Celikey (U/ml) | EMA (titer) | tTG-IgG Celikey (U/ml) | DGP (IgG+IgA) screen (U) | tTG-IgA Immulite 2000 (U/ml) | HLA-DQ2/DQ8 | |
| 1 | − | − | − | 29 (w+) | − | − |
| 2 | − | − | − | 34 (+) | − | − |
| 3 | − | − | 13 (+) | 35 (+) | − | *02 |
| 4 | − | − | − | 47 (+) | − | *02/*0302 |
| 5 | − | − | − | 21 (w+) | − | *0302/*0302 |
| 6 | − | − | − | − | 7.6 (+) | − |
| 7 | − | 1/5 (BL) | − | 34 (+) | 4 | − |
| 8 | − | 1/5 (BL) | − | 32 (+) | 19 (+) | *0302 |
| 9 | − | 1/5 (BL) | − | − | − | *02/*0302 |
| 10 | 5.4 (BL) | 1/5 (BL) | − | 31 (+) | 6.3 (+) | *02 |
| 11 | 5.4 (BL) | 1/5 (BL) | − | 40 (+) | 11 (+) | *02/*02 |
| 12 | − | 1/10 (+) | − | 29 (w+) | 13 (+) | *0302/*0302 |
| 13 | 6.5 (BL) | 1/10 (+) | − | − | 9 (+) | *02/*02 |
| 14 | 19 (+) | 1/10 (+) | 7.6 (BL) | 51.4 (+) | 17 (+) | *0302 |
a
−, negative; BL, borderline; w+, weak positive; +, positive.